With the analysis among 31,031 patents, we discovered top 476 key players by total patent application. F. Hoffmann-La Roche Ltd., AstraZeneca Pharmaceutical Co., Ltd., Boehringer Ingelheim International GmbH are dominant in this area. They take 15.22% of the total patent filing.
F. Hoffmann-La Roche Ltd.
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 1,488
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 1,128
Les Laboratoires Servier SAS
Boehringer Ingelheim Pharma GmbH
Basel-Stadt, Switzerland
Patent: 656
Syngenta Participations AG
New York, United States
Patent: 538
Ohio, United States
Patent: 441
With the analysis among 416 patents, we discovered top 19 start-ups by total patent application. Cellix Bio Pvt Ltd., Institut National de la Santé et de la Recherche Médicale, SyntheX, Inc. are active in this area.
Telangana, India
Patent: 304
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 16
Endogena Therapeutics, Inc.
California, United States
Patent: 13
Baden-Württemberg, Germany
Patent: 9
Actimed Therapeutics Ltd.
New Jersey, United States
Patent: 5
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 5
Arizona, United States
Patent: 3
With the analysis among related 1,265 patents applied in the last 5 years. We discover 487 most active companies in this area. The fast-growing F. Hoffmann-La Roche Ltd., Syngenta Participations AG, Changzhou University take 12.41% of patent filing during this period.
F. Hoffmann-La Roche Ltd.
Syngenta Participations AG
Jiangsu Sheng, China
Patent: 38
Gelderland, Netherlands
Patent: 28
Nordrhein-Westfalen, Germany
Patent: 27
New Jersey, United States
Patent: 24
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 20
Telangana, India
Patent: 18
undefined undefined
Patent: 14
With the analysis among related 1,265 patents in last 5 years, we discover 240 new entrants. Endogena Therapeutics, Inc., East China Normal University, Hualing Pharmaceutical Technology (Shanghai) Co Ltd are the most active new entrants in this area.
Endogena Therapeutics, Inc.
California, United States
Patent: 13
East China Normal University
Shanghai Shi, China
Patent: 8
Hualing Pharmaceutical Technology (Shanghai) Co Ltd
Shanghai Shi, China
Patent: 7
Basel-Stadt, Switzerland
Patent: 7
Zhejiang Institute of Inspection and Quarantine Science and Technology
undefined undefined
Patent: 6
Innovative Molecules GmbH
Nordrhein-Westfalen, Germany
Patent: 5
Ecole Nationale Supérieure de Chimie de Rennes
Bretagne, France
Patent: 5
Nanjing Gasf Pharmaceutical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 4
South China Agricultural University
Guangdong Sheng, China
Patent: 4
With the analysis among 3,106 patents, we discovered top 302 universities and scientific research institutions by total patent application. The European Molecular Biology Laboratory, Council of Scientific & Industrial Research, Shanghai Institute of Materia Medica Chinese Academy of Sciences are dominant in this area. They take 12.52% of the total patent filing.
The European Molecular Biology Laboratory
Baden-Württemberg, Germany
Patent: 102
Council of Scientific & Industrial Research
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 84
Georgia, United States
Patent: 82
Jiangsu Sheng, China
Patent: 64
President & Fellows of Harvard College
Massachusetts, United States
Patent: 51
Université de Rouen Normandie
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 37
North Carolina State University
North Carolina, United States
Patent: 37
North Carolina, United States
Patent: 34